First Wave BioPharma

-$0.0322 (-8.15%) Today
+$0.0162 (+4.47%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FWBI and other ETFs, options, and stocks.

About FWBI

First Wave Biopharma, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of non-systemic therapies for the treatment of gastrointestinal diseases. The firm is involved in a therapeutic development pipeline populated with multiple clinical stage programs built around its proprietary technologies, such as Niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties, and the biologic Adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients.

CEO
James E. Sapirstein
Employees
17
Headquarters
Boca Raton, Florida
Founded
2014

FWBI Key Statistics

Market cap
6.06M
Price-Earnings ratio
—
Dividend yield
—
Average volume
336.79K
High today
$0.39
Low today
$0.34
Open price
$0.38
Volume
348.55K
52 Week high
$9.70
52 Week low
$0.28

FWBI Earnings

-$3.27
-$2.18
-$1.09
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
Expected May 31, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure